Lipoprotein(a): from Causality to Treatment.

Journal Information

Full Title: Curr Atheroscler Rep

Abbreviation: Curr Atheroscler Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of InterestFlorian Kronenberg reports receiving consulting or lecture fees from Novartis, Amgen, Silence Therapeutics, CRISPR Therapeutics and Roche. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by the author. Conflict of Interest Florian Kronenberg reports receiving consulting or lecture fees from Novartis, Amgen, Silence Therapeutics, CRISPR Therapeutics and Roche."

Evidence found in paper:

"Funding Open access funding provided by University of Innsbruck and Medical University of Innsbruck. Florian Kronenberg received research support from the Austrian Research Fund (W-1253)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025